For
the six months ended June 30, 2026 and 2025, respectively, the following common stock equivalents were excluded from the computation
of diluted net loss per share as the result of the computation was anti-dilutive:
SCHEDULE OF ANTI-DILUTIVE BASIC AND DILUTED EARNINGS PER SHARE
| | |
2026 | | |
2025 | |
| | |
Six Months Ended | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| | |
(Shares) | | |
(Shares) | |
| Series A Preferred Stock | |
| 149,892,000 | | |
| 148,445,000 | |
| Stock options | |
| 1,029 | | |
| 864,887 | |
| Warrants | |
| 158,441 | | |
| 754,200 | |
| Total | |
| 151,051,470 | | |
| 150,064,087 | |
|